OnPoint Surgical Appoints Jeremy Laynor as CCO
OnPoint Surgical, Inc., a frontrunner in Augmented Reality (AR) and Artificial Intelligence (AI) technology for spinal procedures, has recently announced the appointment of Jeremy Laynor as their new Chief Commercial Officer (CCO). This strategic move is aimed at accelerating the company’s global growth and enhancing its market presence.
Experience and Expertise of Jeremy Laynor
Mr. Laynor brings with him over twenty years of extensive leadership experience in the medical device, software, and health technology industries. He has proven his capabilities by establishing and scaling commercial teams in both Fortune 100 organizations and dynamic startups, consistently driving revenue growth and market expansion.
In his most recent position as Senior Vice President of Global Sales at Providence Medical Technology, Laynor was instrumental in significantly increasing revenues. He led a highly efficient direct sales team and an international distribution network, achieving remarkable sales outcomes. Previous roles at Paradigm Spine, Medtronic, and Cardinal Health have further honed his skills in crafting effective sales strategies, enhancing surgeon education initiatives, and developing innovative marketing models tailored for ambulatory surgery centers.
The Importance of this Appointment
Philipp Lang, M.D., the Chief Executive Officer of OnPoint Surgical, expressed enthusiasm about Laynor’s appointment, stating that “Jeremy is an exceptional commercial leader whose deep expertise in orthopedic and spine markets, along with his track record of scaling global sales organizations, will be transformative for OnPoint.” Lang emphasized that Laynor’s leadership would be pivotal as the company seeks to diversify its surgical applications and increase widespread adoption of its advanced AR-AI guidance systems.
Laynor's Vision for OnPoint
Upon accepting his new role, Laynor shared his excitement about joining OnPoint, describing the company’s AR-AI technology as a game-changer in terms of surgical accuracy, safety, and efficiency. He highlighted the comprehensive intellectual property portfolio owned by OnPoint and the potential for further clinical applications, positioning the company as a leader in the future of surgical navigation.
About OnPoint Surgical and Its Innovations
The OnPoint family comprises OnPoint Surgical, OnPoint Medical, OnPoint Knee, OnPoint Hip, and OnPoint Sports—all dedicated to advancing medical technology through Augmented Reality and machine learning for various surgical practices. These companies are pushing the boundaries with their AR-AI technology, which is being developed for spinal, neurosurgical, orthopedic, and robotic procedures, among others.
With over 50 patents granted across multiple regions including the U.S., China, and the EU, OnPoint has built a robust intellectual property foundation specifically aimed at enhancing AR guidance in various surgical specialties.
Frequently Asked Questions
Who is Jeremy Laynor?
Jeremy Laynor is the newly appointed Chief Commercial Officer of OnPoint Surgical, Inc. He has over 20 years of experience in the medical technology field.
What is OnPoint Surgical, Inc. known for?
OnPoint Surgical specializes in Augmented Reality and Artificial Intelligence guidance systems for surgical procedures, particularly in the spinal area.
How will Laynor's role impact the company?
His leadership is expected to enhance commercialization efforts and expedite global growth for OnPoint's innovative technologies.
What sectors does OnPoint focus on?
OnPoint is focused on various sectors including spinal, orthopedic, neurosurgical, and robotic surgical interventions.
How many patents does OnPoint hold?
OnPoint holds more than 50 patents across the U.S., China, and the EU for its AR guidance technologies.
